The ATM-dependent DNA Damage Signaling Pathway
Overview
Authors
Affiliations
Many of the insights that we have gained into the mechanisms involved in cellular DNA damage response pathways have come from studies of human cancer susceptibility syndromes that are altered in DNA damage responses. ATM, the gene mutated in the disorder, ataxia-telangiectasia, is a protein kinase that is a central mediator of responses to DNA double-strand breaks in cells. Recent studies have elucidated the mechanism by which DNA damage activates the ATM kinase and initiates these critical cellular signaling pathways. The SMC1 protein appears to be a particularly important target of the ATM kinase, playing critical roles in controlling DNA replication forks and DNA repair after the damage. A major role for the NBS1 and BRCA1 proteins appears to be in the recruitment of an activated ATM kinase molecule to the sites of DNA breaks so that ATM can phosphorylate SMC1. Generation of mice and cells that are unable to phosphorylate SMC1 demonstrated the importance of SMC1 phosphorylation in the DNA-damage-induced S-phase checkpoint, in determining rates of repair of chromosomal breaks, and in determining cell survival after DNA damage. Focusing on ATM and SMC1, the molecular controls of these pathways is discussed.
DNA Double Strand Break and Response Fluorescent Assays: Choices and Interpretation.
Atkinson J, Bezak E, Le H, Kempson I Int J Mol Sci. 2024; 25(4).
PMID: 38396904 PMC: 10889524. DOI: 10.3390/ijms25042227.
Expression of a large coding sequence: Gene therapy vectors for Ataxia Telangiectasia.
Hirch T, Brander N, Schenk F, Pollmann S, Reichenbach J, Schubert R Sci Rep. 2023; 13(1):19386.
PMID: 37938627 PMC: 10632516. DOI: 10.1038/s41598-023-46332-4.
Review of possible mechanisms of radiotherapy resistance in cervical cancer.
Zhang H, Wang X, Ma Y, Zhang Q, Liu R, Luo H Front Oncol. 2023; 13:1164985.
PMID: 37692844 PMC: 10484717. DOI: 10.3389/fonc.2023.1164985.
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review).
Belenchon I, Congregado Ruiz C, Saez C, Osman Garcia I, Medina Lopez R Int J Mol Sci. 2023; 24(16).
PMID: 37629155 PMC: 10455664. DOI: 10.3390/ijms241612978.
The Role of LncRNAs in the Regulation of Radiotherapy Sensitivity in Cervical Cancer.
Zhang H, Fang C, Feng Z, Xia T, Lu L, Luo M Front Oncol. 2022; 12:896840.
PMID: 35692795 PMC: 9178109. DOI: 10.3389/fonc.2022.896840.